Department of Radiology, Baylor College of Medicine, Houston, TX, 77030, USA.
Department of Radiology, Texas Children's Hospital, Houston, TX, 77030, USA.
Adv Sci (Weinh). 2023 Apr;10(10):e2206435. doi: 10.1002/advs.202206435. Epub 2023 Jan 31.
The first line of treatment for most solid tumors is surgical resection of the primary tumor with adequate negative margins. Incomplete tumor resections with positive margins account for over 75% of local recurrences and the development of distant metastases. In cases of oral cavity squamous cell carcinoma (OSCC), the rate of successful tumor removal with adequate margins is just 50-75%. Advanced real-time imaging methods that improve the detection of tumor margins can help improve success rates,overall safety, and reduce the cost. Fluorescence imaging in the second near-infrared (NIR-II) window has the potential to revolutionize the field due to its high spatial resolution, low background signal, and deep tissue penetration properties, but NIR-II dyes with adequate in vivo performance and safety profiles are scarce. A novel NIR-II fluorophore, XW-03-66, with a fluorescence quantum yield (QY) of 6.0% in aqueous media is reported. XW-03-66 self-assembles into nanoparticles (≈80 nm) and has a systemic circulation half-life (t ) of 11.3 h. In mouse models of human papillomavirus (HPV)+ and HPV- OSCC, XW-03-66 outperformed indocyanine green (ICG), a clinically available NIR dye, and enabled intraoperative NIR-II image-guided resection of the tumor and adjacent draining lymph node with negative margins. In vitro and in vivo toxicity assessments revealed minimal safety concerns for in vivo applications.
对于大多数实体瘤,一线治疗方法是手术切除原发肿瘤并保证切缘阴性。切缘阳性的肿瘤切除不完全占局部复发和远处转移的 75%以上。对于口腔鳞状细胞癌(OSCC),有足够切缘成功切除肿瘤的比率仅为 50-75%。先进的实时成像方法可以提高肿瘤边界的检测能力,有助于提高成功率、整体安全性并降低成本。在第二个近红外(NIR-II)窗口中进行荧光成像具有革命性的潜力,因为它具有高空间分辨率、低背景信号和深组织穿透特性,但具有足够的体内性能和安全特性的 NIR-II 染料却很稀缺。报告了一种新型的 NIR-II 荧光团 XW-03-66,其在水介质中的荧光量子产率(QY)为 6.0%。XW-03-66 自组装成纳米颗粒(≈80nm),系统循环半衰期(t )为 11.3h。在 HPV+和 HPV-OSCC 的小鼠模型中,XW-03-66 优于临床可用的 NIR 染料吲哚菁绿(ICG),并能够实现肿瘤和相邻引流淋巴结的术中 NIR-II 图像引导切除,切缘阴性。体外和体内毒性评估显示,体内应用的安全性问题极小。